HemoMer is a new product in preclinical development by AplaGen Biopharmaceuticals. It combines EPO mimetic peptides with hydroxyethylstarch (HES). This pushes it above the filtration threshold of the kidneys. Half Life and efficacy are both improved.
What's the rumor mill on this? Anybody in cycling having heard/seen/encountered it? Second and third hand reports? Anything?
What's the rumor mill on this? Anybody in cycling having heard/seen/encountered it? Second and third hand reports? Anything?